Epstein Secrets

From: Sent: To: Subject: lan Osborne 9/7/2012 2:40:14 AM Jeffrey Epstein [[email protected]] Re: Jawbone/Mort What else are you interested in? Peter is best for currency; maybe Reid Hoffman (fatty at LinkedIn) or Dave

Subject: lan Osborne 9/7/2012 2:40:14 AM Jeffrey Epstein [[email protected]] Re: Jawbone/Mort What els

From: Sent: To: Subject: lan Osborne 9/7/2012 2:40:14 AM Jeffrey Epstein [[email protected]] Re: Jawbone/Mort What else are you interested in? Peter is best for currency; maybe Reid Hoffman (fatty at LinkedIn) or Dave Morin (Path) or Drew Houston (Dropbo

sage: From: "Jacoby, Craig" Date: September 5, 2012 7:27:21 PM EDT To: "Darren Indyke" Ce: "Hosain Rahman" , "Ian Osborne" , "Jacoby, Craig" Subject: Jawbone/Mort Hi Darren, Just checking back in on the Jawbone investment. Thanks for sending across your comments. If possible, we would like to avoid a situa

From: Richard Kahn To: Jeffrey Epstein <[email protected]> Subject: Fwd: Jawbone Date: Sun, 15 Jan 2017 14:01:18 +0000 Richard Kahn HBRK Associates Inc. 575 Lexington Avenue, 4th

From: Richard Kahn To: Jeffrey Epstein <[email protected]> Subject: Fwd: Jawbone D

From: Richard Kahn To: Jeffrey Epstein <[email protected]> Subject: Fwd: Ja

told one of its business partners it couldn't make an August payment deadline. Jawbone breached covenants on its S300 million loan from BlackRock, Jawbone confirmed, prompting the investor to push Jawbone to put itself on the market. That sale process didn't lead to any bids. Yet after all that, CEO H

Sent: Thursday, October 20, 2016 10:14 PM To: Jeffrey Epstein Subject: Jawbone Despite Challenges, J

From: Richard Kahn < Sent: Thursday, October 20, 2016 10:14 PM To: Jeffrey Epstein Subject: Jawbone Despite Challenges, Jawbone's Rahman Still Upbeat By Reed =lbergotti Oct. 20, 2016 12:48 PM =DT • Mentions Jawbone, Hosain =ah

Thursday, October 20, 2016 10:14 PM To: Jeffrey Epstein Subject: Jawbone Despite Challenges, Jawbone's

eally, really excited about what we're doing and what we'=e building but it is a shift from where we've been before,"=he said. A former employee at Jawbone said the company has considered =eveloping a blood glucose monitor similar to those used by =iabetics. Earlier this month the company told =mployees

ibble, Jr. Joseph S. Grinstein Bryce T. Barceb Jeffrey David SUSMAN GODFREY L.L.P. 1000 Louisiana, Sui

s. Fitbit filed its Complaint on November 2, 2015, in order to protect its domestic industry from patent infringement by the importation and sale of Jawbone's UP Move and two newest (at the time) wearable activity trackers, the UP3 and UP4, both released in 2015. Today, however, Jawbone appears to be a

s, CA 90067 Attorneys for Defendant Jason Child Jeffrey Goldenhersh Skadden, Arps, Slate, Meagher & Flom

e signed 20 were that: 21 • The products were subject to a lien in favor of North American 22 Production Sharing, Inc. ("NAPS"), as a result of Jawbone's failure 23 to pay hundreds of thousands of dollars in storage and handling fees; 24 • As a result of Jawbone's intention not to pay and failure

From: jeffrey E. <[email protected]> Sent: Wednesday, February 10, 2016 7:08 PM To: Richard Kahn Subject: Re: Series 9 Funding Yes On Wednesday, 10 February

To: Richa=d Kahn < <javascript:_e(%7B%7D,icvmit <=span> Rich, I am writing to confirm tha= the $125,000,000 Series 9 investment was funded into Jawbone's accoun= with no restrictions on the use of funds. Thanks= Andrew EFTA_R1_01583961 EFTA02472144 please note T=e information contained in thi